Vestmark Advisory Solutions, Inc. Bristol Myers Squibb CO Transaction History

Vestmark Advisory Solutions, Inc.

$6.16 Billion
Q2 2025

A detailed history of Vestmark Advisory Solutions, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Vestmark Advisory Solutions, Inc. holds 6,420 shares of BMY stock, worth $279,526. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,420

Previous 13,771 53.38%

Holding current value

$279,526

Previous $839,000 64.6%

% of portfolio

0.0%

Previous 0.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 06, 2025	SELL	$44.12 - $59.6 $324,326 - $438,119	-7,351 Reduced 53.38%	6,420 $297,000
Q1 2025 May 13, 2025	BUY	$53.9 - $63.11 $340,863 - $399,107	6,324 Added 84.92%	13,771 $839,000
Q4 2024 Feb 06, 2025	BUY	$51.92 - $59.94 $386,648 - $446,373	7,447 New	7,447 $421,000
Q2 2023 Aug 07, 2023	BUY	$63.71 - $70.74 $260,573 - $289,326	4,090 Added 11.28%	40,339 $2.58 Million
Q1 2023 May 09, 2023	BUY	$65.71 - $74.53 $49,019 - $55,599	746 Added 2.1%	36,249 $2.51 Million
Q4 2022 Jan 20, 2023	SELL	$68.48 - $81.09 $44,580 - $52,789	-651 Reduced 1.8%	35,503 $0
Q3 2022 Nov 03, 2022	BUY	$0.13 - $76.84 $278 - $164,668	2,143 Added 6.3%	36,154 $2.57 Million
Q2 2022 Aug 04, 2022	SELL	$72.62 - $79.98 $203,118 - $223,704	-2,797 Reduced 7.6%	34,011 $2.62 Million
Q1 2022 Apr 27, 2022	SELL	$61.48 - $73.72 $1.35 Million - $1.62 Million	-21,968 Reduced 37.38%	36,808 $2.69 Million
Q4 2021 Jan 31, 2022	BUY	$53.63 - $62.52 $145,444 - $169,554	2,712 Added 4.84%	58,776 $3.67 Million
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $186,503 - $218,465	3,152 Added 5.96%	56,064 $3.32 Million
Q2 2021 Aug 09, 2021	BUY	$61.91 - $67.42 $224,114 - $244,060	3,620 Added 7.34%	52,912 $3.54 Million
Q1 2021 May 10, 2021	SELL	$59.34 - $66.74 $56,313 - $63,336	-949 Reduced 1.89%	49,292 $3.11 Million
Q4 2020 Feb 04, 2021	BUY	$57.74 - $65.43 $402,678 - $456,308	6,974 Added 16.12%	50,241 $3.12 Million
Q3 2020 Oct 19, 2020	BUY	$57.43 - $63.64 $1.09 Million - $1.21 Million	19,007 Added 78.35%	43,267 $2.61 Million
Q2 2020 Aug 13, 2020	BUY	$54.82 - $64.09 $278,595 - $325,705	5,082 Added 26.5%	24,260 $1.43 Million
Q1 2020 May 06, 2020	SELL	$46.4 - $67.43 $47,560 - $69,115	-1,025 Reduced 5.07%	19,178 $1.07 Million
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $450,271 - $587,338	9,150 Added 82.78%	20,203 $1.3 Million
Q3 2019 Nov 05, 2019	BUY	$42.77 - $50.71 $275,481 - $326,623	6,441 Added 139.66%	11,053 $560,000
Q2 2019 Aug 20, 2019	SELL	$44.62 - $49.34 $136,269 - $150,684	-3,054 Reduced 39.84%	4,612 $209,000
Q1 2019 May 14, 2019	BUY	$45.12 - $53.8 $345,889 - $412,430	7,666 New	7,666 $366,000

Others Institutions Holding BMY

# of Institutions

2,674

Shares Held

1.64B

Call Options Held

22.4M

Put Options Held

25.4M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $92.6B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestmark Advisory Solutions, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Vestmark Advisory Solutions, Inc. with notifications on news.

Account

Vestmark Advisory Solutions, Inc. Bristol Myers Squibb CO Transaction History